Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Toronto
SEC filing record 1 source field available
Fiscal year end
31 December
Aptose Biosciences Inc. has filed 1,073 SEC EDGAR filings since 14 Feb 1997

SEC filing history

Showing 576-600 of 865 matching filings.

Per page
25
Current page
24
F-10 File 333-222909

F-10

Filing date
07 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

6-K filing

Filing date
01 Feb 2018
Reporting date
31 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-49893

SC 13G/A

Filing date
19 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
02 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-221783

424B3

Filing date
29 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
26 Dec 2017
Reporting date
26 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-221783

EFFECT filing

Filing date
21 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
19 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-1/A File 333-221783

F-1/A

Filing date
19 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
11 Dec 2017
Reporting date
11 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
11 Dec 2017
Reporting date
11 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
07 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-1 File 333-221783

F-1

Filing date
28 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
14 Nov 2017
Reporting date
14 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
14 Nov 2017
Reporting date
14 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
07 Nov 2017
Reporting date
07 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
01 Nov 2017
Reporting date
01 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

6-K filing

Filing date
30 Oct 2017
Reporting date
30 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

6-K

Filing date
30 Oct 2017
Reporting date
27 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
19 Sep 2017
Reporting date
19 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
12 Sep 2017
Reporting date
12 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
05 Sep 2017
Reporting date
05 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
09 Aug 2017
Reporting date
08 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-32001

FORM 6-K

Filing date
08 Aug 2017
Reporting date
08 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .